Urinary stones in HIV-1-positive patients treated with indinavir.
about
Symptomatic crystalluria associated with indinavir.Urologic complications of HIV and AIDS.Microalbuminuria in HIV infection.HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.The CARI guidelines. Kidney stones epidemiology.Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.Hospitalization due to adverse drug reactions and drug interactions before and after HAART.Kidney stone analysis: "Give me your stone, I will tell you who you are!".HIV medication-based urolithiasis.Single-dose pharmacokinetics of indinavir and the effect of food.Structure-activity relationship studies on a novel family of specific HIV-1 reverse transcriptase inhibitors.Acute interstitial nephritis secondary to the administration of indinavir.Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy.Indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus.Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.In-vitro crystallization of indinavir in the presence of ritonavir and as a function of pH.Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.Developmental toxicity of the HIV-protease inhibitor indinavir in rats.Failure of accommodation in patients with HIV infection.Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.
P2860
Q34122511-DA2B33E4-A270-4241-9D84-081C35E4FB3BQ34918218-21644706-B2BF-47B4-8D9E-95FF749F9987Q35293817-1C9A7593-D870-4625-B9D4-92DB949C1433Q36451062-2D3C0B9B-E97C-46C0-8930-70EFBF9EF2D7Q36742496-62A0A064-F413-44F5-A35E-B04C464D7EE6Q36910943-B2070493-D83E-409C-BFEE-A4AAE8FDB4B2Q37045107-AD521693-8232-4662-8A9C-9CD8D722F170Q38281436-A4FC4BF3-E5EE-4344-9B38-BE0DC4CB2547Q38411142-78826CC2-A153-4484-A9A2-242B9B4E0495Q39556676-90D7BD4B-0E6F-4183-A79D-B09A021D7787Q40604278-14507D49-05FA-4C63-B119-622E6D39998BQ42540802-43161CC4-41F4-48ED-BF56-5D4A832CB345Q42733929-200C48E0-FC55-42A3-AB70-6BBCAB15A0DEQ44098426-EC67D2D7-11EB-44F4-83F5-224BF258CBA9Q44396659-F57E0AC9-BDE6-4C33-BC87-2D03F78BE064Q44494632-1DB580CB-4D10-411F-9587-5FCD6A88111AQ49629769-1D8987FD-BB5C-4530-8C70-923276401BA7Q52164434-972FD027-CC0B-4D51-AF47-8DCAF73DDE56Q53881001-FC3EE06A-41E8-49F5-B32F-D7B2A38FDEE1Q54240869-0AA9C0F7-97BE-4341-87EF-89EE0546BCB8
P2860
Urinary stones in HIV-1-positive patients treated with indinavir.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Urinary stones in HIV-1-positive patients treated with indinavir.
@en
Urinary stones in HIV-1-positive patients treated with indinavir.
@nl
type
label
Urinary stones in HIV-1-positive patients treated with indinavir.
@en
Urinary stones in HIV-1-positive patients treated with indinavir.
@nl
prefLabel
Urinary stones in HIV-1-positive patients treated with indinavir.
@en
Urinary stones in HIV-1-positive patients treated with indinavir.
@nl
P2093
P1433
P1476
Urinary stones in HIV-1-positive patients treated with indinavir.
@en
P2093
P304
P356
10.1016/S0140-6736(05)62506-8
P407
P577
1997-05-01T00:00:00Z